,Variant_classification,Gene_classification,Comment,Difficultregion,CNV-SNV,ID,OMIM_Phenotype,Disease,Clinical_synopsis,OMIM_Link,Uniprot,Inheritance,Zygosity,CHR,POS,REF,ALT,Flank,Repeat_flag,FILTER,FORMAT,VAF,Pileup_data,Mutation_type,Gene_name,Entrez_Gene_Id,In_Key_Gene,HGVS_nomenclature,HGMD_transcript,ExonNumber,PolarChange,1000G_ASN_AF,1000G_ALL_AF,ESP6500_AC,ESP6500_AF,gnomAD_exome_ALL,gnomAD_exome_EAS,gnomAD_genome_ALL,gnomAD_genome_EAS,ExAC_EAS_HomoAlt_Count,ExAC_EAS_AC,ExAC_EAS_AF,ExAC_HomoAlt_Count,ExAC_AC,ExAC_AF,In_house_freq,In_house_count,ExAC_Link,ExAC_MisZ,ExAC_Expected,ExAC_observed,ExAC_PLI,PLI_Link,Phylop_Vertebrate_score,Phylop_Mammal_score,SIFT_score,SIFT_prediction,Polyphen2_HDIV_score,Polyphen2_HDIV_pred,Polyphen2_HVAR_score,Polyphen2_HVAR_pred,LRT_score,LRT_prediction,Mutationtatser_score,Mutationtatser_prediction,Gerp++,CADD,Rs_ID,Swiss_prot_function,Swiss_prot_disease_association,Swiss_prot_post_translational_modifications,Swiss_prot_expression,HGMD_mutation_type,HGMD_variant_class,HGMD_disease,HGMD_pubmed_ID,HGMD_indel_type,HGMD_Indel_class,HGMD_indel_disease,HGMD_indel_PMID,HGMD_nearby_alleles,Clinvar,Clinvar_Link,CosmicID,Cosmic_Occurence,Mother_zygosity,Mother_filter,Mother_format,Mother_VAF,Mother_pileup,Father_zygosity,Father_filter,Father_format,Father_VAF,Father_pileup,Recessive,Com_het,De_novo,Other_relatives,Covered,Less_20,GO_BP,GO_CC,GO_MF,KEGG_PATHWAY,PID_PATHWAY,BIOCARTA_PATHWAY,REACTOME_PATHWAY,pheno_rank,intersect_rank,CaseID
12,.,.,HGMD|novel|possible_comhet,Name=LowComplexity,.,CS000030,.,.,.,.,.,.,Het,19,39075698,T,C,.,.,PASS,0/1:46:78,58.97,",,c,ccCc,Cccc,c,cCcCcccc,c,,cc,c.,,CCc.C,.,cCc,,,C.c,.cCCcc,,cC,CC,c,.,c.,C^]C^]c",missense_variant;missense_variant,RYR1,11184,.,NM_001042723.1(RYR1):c.14747T>C(p.Phe4916Ser);NM_000540.2(RYR1):c.14762T>C(p.Phe4921Ser),NM_000540.2,exon101(105);exon102(106),NP=>P0;NP=>P0,.,.,.,.,.,.,.,.,.,.,.,.,.,.,0.00117785630153,1/849,.,4.44,179.9,50,0.0,http://exac.broadinstitute.org/gene/ENSG00000196218,0.55325,.,0,D,0.999,D,0.996,D,0.000,U,1.000,D,5.08,16.20,rs118192156,.,.,.,.,NM_000540.2(RYR1):c.14762T>C(p.F4921S),DM,Central core disease,16621918,.,.,.,.,"NM_000540.2(RYR1):c.14761_14762delTTinsAC,DM,Central core disease,16621918",.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,activation of JUN kinase activity (GO:0007257)|activation of MAPKKK activity (GO:0000185)|cell proliferation (GO:0008283)|intracellular signal transduction (GO:0035556)|peptidyl-serine phosphorylation (GO:0018105)|protein autophosphorylation (GO:0046777)|protein phosphorylation (GO:0006468)|response to stress (GO:0006950),membrane (GO:0016020),ATP binding (GO:0005524)|MAP kinase kinase kinase kinase activity (GO:0008349)|protein kinase activity (GO:0004672)|protein serine/threonine kinase activity (GO:0004674)|small GTPase regulator activity (GO:0005083),.,.,.,.,4,0,CS000030
62,.,.,HGMD|OMIM,.,.,CS000030,260920;610377;175900,"Hyper-IgD syndrome;Mevalonic aciduria;Porokeratosis 3, multiple types","1.$$$mimNumber,260920###prefix,####preferredTitle,HYPER-IgD SYNDROME; HIDS###inheritance,Autosomal recessive ###headAndNeckEyes,Retinitis pigmentosa (in some patients) ;###headAndNeckEyes,Night blindness ;###headAndNeckEyes,Visual field loss ;###headAndNeckEyes,Optic disc pallor ;###headAndNeckEyes,Attenuated retinal vessels ;###headAndNeckEyes,Peripheral atrophy of retinal pigment epithelium ;###headAndNeckEyes,Intraretinal pigmentation ;###headAndNeckEyes,Decreased or undetectable rod responses on electroretinography ;###headAndNeckEyes,Reduced cone responses on electroretinography ###abdomenSpleen,Splenomegaly (in childhood) ###abdomenGastrointestinal,Abdominal pain ;###abdomenGastrointestinal,Diarrhea ;###abdomenGastrointestinal,Vomiting ###skeletalLimbs,Arthralgias ;###skeletalLimbs,Arthritis ###skinNailsHairSkin,Rash (erythematous macules or papules) ###neurologicCentralNervousSystem,Headache ###hematology,Leukocytosis (mean leukocyte count 18.7 x 10(9)/L) ;###hematology,Neutrophilia ###immunology,Elevated polyclonal IgD (equal to or greater than 100 IU/ml) ;###immunology,Elevated IgA (equal to or greater than 2.6g/L) ;###immunology,Lymphadenopathy (cervical, inguinal, axillary) ###laboratoryAbnormalities,Mildly elevated urinary mevalonic acid ;###laboratoryAbnormalities,Elevated erythrocyte sedimentation rate (mean 90mm/h) ###miscellaneous,Prodromal symptoms include nasal congestion, dry throat, severe fatigue, vertigo, and headache ;###miscellaneous,Recurrent febrile crises preceded by chills and accompanied by headache and bilateral cervical lymphadenopathy ;###miscellaneous,Febrile attacks disappear in adulthood in some patients ;###miscellaneous,Onset of symptoms less than one year ;###miscellaneous,Allelic to mevalonic aciduria ();###miscellaneous,Length of attack, 3 to 7 days ;###miscellaneous,Frequency of attack, monthly - bimonthly ###molecularBasis,Caused by mutation in the mevalonate kinase gene (MVK, ) 2.$$$mimNumber,610377###prefix,####preferredTitle,MEVALONIC ACIDURIA; MEVA###inheritance,Autosomal recessive ###growthHeight,Short stature ###growthOther,Failure to thrive ###headAndNeckHead,Microcephaly ;###headAndNeckHead,Dolichocephaly ;###headAndNeckHead,Wide, irregular fontanels ###headAndNeckFace,Triangular face ###headAndNeckEars,Low-set ears ;###headAndNeckEars,Posteriorly rotated ears ###headAndNeckEyes,Downslanting palpebral fissures ;###headAndNeckEyes,Blue sclerae ;###headAndNeckEyes,Central cataracts ;###headAndNeckEyes,Nystagmus ;###headAndNeckEyes,Nuclear cataract (in some patients) Retinal dystrophy (in some patients) ;###headAndNeckEyes,Undetectable rod and cone responses on electroretinography ;###headAndNeckEyes,Attenuation of retinal vessels ;###headAndNeckEyes,Moderate atrophy of optic disc ###abdomenLiver,Fluctuating hepatomegaly ###abdomenSpleen,Fluctuating splenomegaly ###abdomenGastrointestinal,Vomiting ;###abdomenGastrointestinal,Diarrhea ###skeletalSpine,Kyphoscoliosis (in some patients) ###skeletalLimbs,Arthralgias ###skinNailsHairSkin,Morbilliform rash ;###skinNailsHairSkin,Edema ###neurologicCentralNervousSystem,Psychomotor retardation ;###neurologicCentralNervousSystem,Hypotonia ;###neurologicCentralNervousSystem,Progressive ataxia (onset second year of life) ;###neurologicCentralNervousSystem,Developmental delay ;###neurologicCentralNervousSystem,Cerebellar atrophy ;###neurologicCentralNervousSystem,Cerebral atrophy ;###neurologicCentralNervousSystem,Agenesis of cerebellar vermis ###hematology,Normocytic hypoplastic anemia ;###hematology,Leukocytosis ;###hematology,Thrombocytopenia ###immunology,Elevated IgD ###laboratoryAbnormalities,Elevated serum creatine kinase ;###laboratoryAbnormalities,Elevated transaminases ;###laboratoryAbnormalities,Serum cholesterol low or normal ;###laboratoryAbnormalities,Elevated leukotriene E(4) ;###laboratoryAbnormalities,Decreased ubiquinone-10 ;###laboratoryAbnormalities,Elevated urinary mevalonic acid ###miscellaneous,Recurrent febrile crises with lymphadenopathy, hepatosplenomegaly, vomiting, and diarrhea ;###miscellaneous,Onset of crises in early childhood ;###miscellaneous,Febrile crises decrease with age, with ataxia becoming the predominant symptom (in some patients) ;###miscellaneous,Rash, edema, and arthralgia may occur during crisis ;###miscellaneous,Allelic to hyperimmunoglobulinemia D syndrome (HIDS, )###molecularBasis,Caused by mutation in the mevalonate kinase gene (MVK, ) 3.$$$mimNumber,175900###prefix,####preferredTitle,POROKERATOSIS 3, MULTIPLE TYPES; POROK3###inheritance,Autosomal dominant ###skinNailsHairSkin,Small, annular, anhidrotic keratotic lesions located predominantly on sun-exposed areas ;###skinNailsHairSkin,Central atrophic area with peripheral keratotic ridge ;###skinNailsHairSkin,Disseminated superficial actinic porokeratosis ;###skinNailsHairSkin,Non-actinic disseminated superficial porokeratosis ;###skinNailsHairSkin,Porokeratosis of Mibelli ;###skinNailsHairSkin,Giant plaque of porokeratosis ptychotropica ;###skinNailsHairSkin,Hyperkeratotic porokeratosis ;###skinNailsHairSkin,Widespread keratinized plaques (in some patients) ;###skinNailsHairSkin,Verrucous proliferation (in some patients) ;###skinNailsHairSkin,Linear porokeratosis (rare) ###skinNailsHairSkinHistology,Epidermal atrophy ;###skinNailsHairSkinHistology,Vertical columns of parakeratosis (cornoid lamella) overlying absent or reduced granular layer with dyskeratotic cells ;###skinNailsHairSkinHistology,Nonspecific perivascular infiltrate of chronic inflammatory cells ###skinNailsHairNails,Nail dystrophy (in some patients) ###miscellaneous,Onset of lesions usually in first through fourth decades of life, but may occur as late as the seventh decade ;###miscellaneous,Intrafamilial variability ###molecularBasis,Caused by mutation in the mevalonate kinase gene (MVK, )",https://www.omim.org/entry/260920;https://www.omim.org/entry/610377;https://www.omim.org/entry/175900,.,Autosomal recessive;Autosomal dominant,Het,12,110012660,G,A,.,.,PASS,0/1:19:47,40.43,"..AA..Aa,,a.,.,Aaa.,,AA,,A,.a,,,AaAaaaA..,,^]A",synonymous_variant;synonymous_variant,MVK,4598,.,NM_000431.2(MVK):c.33G>A(p.Pro11=);NM_001114185.1(MVK):c.33G>A(p.Pro11=),NM_000431.3,exon2(11);exon2(11),.;.,.,.,0,0,3.348e-05,0.0004,.,.,0,2,0.00034,0,3,0.000041,0.00471142520612,4/849,http://exac.broadinstitute.org/variant/12-110012660-G-A,1.13,15.0,5,0.04,http://exac.broadinstitute.org/gene/ENSG00000110921,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,"NM_000431.3(MVK):c.34G>C(p.G12R),DM,Disseminated superficial actinic porokeratosis,22983302",.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,"cholesterol biosynthetic process (GO:0006695)|isopentenyl diphosphate biosynthetic process, mevalonate pathway (GO:0019287)|isoprenoid biosynthetic process (GO:0008299)|negative regulation of inflammatory response (GO:0050728)|small molecule metabolic process (GO:0044281)",cytosol (GO:0005829)|extracellular vesicular exosome (GO:0070062),ATP binding (GO:0005524)|identical protein binding (GO:0042802)|mevalonate kinase activity (GO:0004496),.,.,.,.,75,3,CS000030
165,.,.,OMIM|novel,.,.,CS000030,253290;601462;608930,"Multiple pterygium syndrome, lethal type;Myasthenic syndrome, congenital, 1A, slow-channel;Myasthenic syndrome, congenital, 1B, fast-channel","1.$$$mimNumber,253290###prefix,####preferredTitle,MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE; LMPS###inheritance,Autosomal recessive ###growthOther,Intrauterine growth retardation ###headAndNeckFace,Dysmorphic facies ;###headAndNeckFace,Micrognathia ###headAndNeckEars,Low-set ears ###headAndNeckEyes,Epicanthal folds ;###headAndNeckEyes,Hypertelorism ###headAndNeckNose,Flat nose ###headAndNeckMouth,Cleft lip/palate ;###headAndNeckMouth,Cleft palate ###headAndNeckNeck,Cystic hygroma ;###headAndNeckNeck,Jugular lymphatic obstruction sequence ###cardiovascularHeart,Hypoplastic heart ###respiratoryLung,Hypoplastic lungs ###chestRibsSternumClaviclesAndScapulae,Thin ribs ###skeletal,Fractures ;###skeletal,Congenital bone fusions ###skeletalSpine,Abnormal cervical curvature ;###skeletalSpine,Spinal fusion ###skeletalLimbs,Joint dislocations ;###skeletalLimbs,Flexion contractures ###skeletalHands,Microbrachydactyly ###skinNailsHairSkin,Multiple pterygia ###muscleSoftTissue,Generalized amyoplasia ###neurologicCentralNervousSystem,Early severe fetal akinesia sequence ###metabolicFeatures,Malignant hyperthermia ###prenatalManifestations,Hydrops ###prenatalManifestationsAmnioticFluid,Polyhydramnios ###miscellaneous,Lethal ###molecularBasis,Caused by mutation in the cholinergic receptor, nicotinic, alpha polypeptide-1, muscle gene (CHRNA1, );###molecularBasis,Caused by mutation in the cholinergic receptor, nicotinic, delta polypeptide gene (CHRND, );###molecularBasis,Caused by mutation in the cholinergic receptor, nicotinic, gamma polypeptide gene (CHRNG, ) 2.$$$mimNumber,601462###prefix,####preferredTitle,MYASTHENIC SYNDROME, CONGENITAL, 1A, SLOW-CHANNEL; CMS1A###inheritance,Autosomal dominant ###headAndNeckEyes,Ophthalmoplegia ;###headAndNeckEyes,Ptosis ###headAndNeckMouth,High-arched palate (in some patients) ###respiratory,Respiratory insufficiency, episodic ###abdomenGastrointestinal,Feeding difficulties ;###abdomenGastrointestinal,Dysphagia ###muscleSoftTissue,Generalized muscle weakness due to defect at the neuromuscular junction ;###muscleSoftTissue,Cervical muscle weakness ;###muscleSoftTissue,Scapular muscle weakness ;###muscleSoftTissue,Extensor finger muscle weakness ;###muscleSoftTissue,Atrophy of affected muscles, especially intrinsic hand muscles ;###muscleSoftTissue,Chronic fatigable muscles ;###muscleSoftTissue,Dysarthria ;###muscleSoftTissue,Repetitive compound muscle action potentials (CMAP) in response to single stimulus ;###muscleSoftTissue,Decremental CMAP response to repetitive nerve stimulation seen on EMG ;###muscleSoftTissue,Prolonged miniature endplate potentials (MEPP) ;###muscleSoftTissue,Prolonged miniature endplate currents (MEPC) ;###muscleSoftTissue,Increased opening duration of acetylcholine receptor (AChR)-induced ion channels ;###muscleSoftTissue,Focal degeneration of junctional folds ('honeycombed' appearance) see on muscle biopsy ;###muscleSoftTissue,Thickened endplate basal lamina seen on muscle biopsy ;###muscleSoftTissue,Decreased size of nerve terminals seen on muscle biopsy ;###muscleSoftTissue,Progressive widening of synaptic clefts that are filled with amorphous debris seen on muscle biopsy ;###muscleSoftTissue,Calcium accumulation in junctional folds seen on muscle biopsy ;###muscleSoftTissue,Secondary loss of AChR from junctional folds seen on muscle biopsy ###miscellaneous,Variable age at onset ;###miscellaneous,Usually symptomatic in adulthood with history of weakness since infancy or childhood ;###miscellaneous,Exacerbation of symptoms during or after pregnancy ;###miscellaneous,Progressive disorder due to secondary myopathy ;###miscellaneous,Poor response to acetylcholinesterase inhibitors ;###miscellaneous,Quinidine therapy may be effective ;###miscellaneous,Fluoxetine therapy may be effective ###molecularBasis,Caused by mutation in the cholinergic receptor, nicotinic, alpha polypeptide-1 gene (CHRNA1, ) 3.$$$mimNumber,608930###prefix,####preferredTitle,MYASTHENIC SYNDROME, CONGENITAL, 1B, FAST-CHANNEL; CMS1B###inheritance,Autosomal dominant ;###inheritance,Autosomal recessive ###headAndNeckFace,Facial muscle weakness ###headAndNeckEyes,Ptosis ;###headAndNeckEyes,Ophthalmoparesis ###headAndNeckNeck,Neck muscle weakness ###respiratory,Respiratory insufficiency due to muscle weakness (especially in infancy) ###abdomenGastrointestinal,Poor feeding due to muscle weakness ;###abdomenGastrointestinal,Poor suck ;###abdomenGastrointestinal,Dysphagia ###muscleSoftTissue,Hypotonia, neonatal ;###muscleSoftTissue,Generalized muscle weakness ;###muscleSoftTissue,Bulbar muscle weakness ;###muscleSoftTissue,Easy fatigability ;###muscleSoftTissue,Inability to stand or walk (in severe cases) ;###muscleSoftTissue,Gowers sign ;###muscleSoftTissue,Dysarthria ;###muscleSoftTissue,Decremental compound muscle action potential (CMAP) in response to repetitive nerve stimulation seen on EMG ;###muscleSoftTissue,Small miniature endplate potentials (MEPP) ;###muscleSoftTissue,Small miniature endplate currents (MEPC) ;###muscleSoftTissue,Shortened acetylcholine receptor (AChR)-induced ion channel opening ;###muscleSoftTissue,Decreased numbers of AChR seen on muscle biopsy ;###muscleSoftTissue,Increased numbers of endplate regions seen on muscle biopsy ;###muscleSoftTissue,Increased length of endplate regions seen on muscle biopsy ;###muscleSoftTissue,Preserved nerve terminals seen on muscle biopsy ;###muscleSoftTissue,Preserved junctional structure seen on muscle biopsy ###neurologicCentralNervousSystem,Delayed motor development due to muscle weakness ###voice,Weak cry ###miscellaneous,Onset in infancy or early childhood ;###miscellaneous,Variable severity ;###miscellaneous,Favorable response to acetylcholinesterase inhibitors ;###miscellaneous,Favorable response to 3,4-diaminopyridine ;###miscellaneous,Rare autosomal dominant inheritance has been reported ###molecularBasis,Caused by mutations in the cholinergic receptor, nicotinic, alpha polypeptide-1 gene (CHRNA1, )",https://www.omim.org/entry/253290;https://www.omim.org/entry/601462;https://www.omim.org/entry/608930,.,"Autosomal recessive;Autosomal dominant;Autosomal recessive, Autosomal dominant",Het,2,175614719,G,T,.,.,PASS,0/1:17:37,45.95,".$.T..T.T.,Tt.TT..TTtT,.T....T.T...T^]T",missense_variant;missense_variant,CHRNA1,1134,.,NM_000079.3(CHRNA1):c.957C>A(p.His319Gln);NM_001039523.2(CHRNA1):c.1032C>A(p.His344Gln),NM_000079.3,exon7(9);exon8(10),P+=>P0;P+=>P0,.,.,.,.,.,.,.,.,.,.,.,.,.,.,0.00117785630153,1/849,.,0.64,15.0,10,0.0,http://exac.broadinstitute.org/gene/ENSG00000138435,0.55325,.,0,D,1.0,D,0.999,D,0.000,D,1.000,D,3.6,16.21,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,cation transmembrane transport (GO:0098655)|cation transport (GO:0006812)|ion transmembrane transport (GO:0034220)|muscle cell cellular homeostasis (GO:0046716)|musculoskeletal movement (GO:0050881)|neuromuscular junction development (GO:0007528)|neuromuscular process (GO:0050905)|neuromuscular synaptic transmission (GO:0007274)|neuron cellular homeostasis (GO:0070050)|neuronal action potential (GO:0019228)|regulation of membrane potential (GO:0042391)|signal transduction (GO:0007165)|skeletal muscle contraction (GO:0003009)|skeletal muscle tissue growth (GO:0048630)|synaptic transmission (GO:0007268)|transport (GO:0006810),acetylcholine-gated channel complex (GO:0005892)|cell junction (GO:0030054)|cell surface (GO:0009986)|neuromuscular junction (GO:0031594)|plasma membrane (GO:0005886)|postsynaptic membrane (GO:0045211),acetylcholine binding (GO:0042166)|acetylcholine receptor activity (GO:0015464)|acetylcholine-activated cation-selective channel activity (GO:0004889)|ion channel activity (GO:0005216),.,.,.,.,56,1,CS000030
248,.,.,HGMD|novel|possible_comhet,Name=LowComplexity,.,CS000030,.,.,.,.,.,.,Het,19,39075697,T,A,.,.,PASS,0/1:44:76,57.89,",,a,aaAa,Aaaa,a,aAaAaaaa,a,,aa,a.,,Aa.A,.,aAa,,,A.a,.aAAaa,,A,AA,a,.,a.,A",missense_variant;missense_variant,RYR1,11184,.,NM_000540.2(RYR1):c.14761T>A(p.Phe4921Ile);NM_001042723.1(RYR1):c.14746T>A(p.Phe4916Ile),NM_000540.2,exon102(106);exon101(105),NP=>NP;NP=>NP,.,.,.,.,.,.,.,.,.,.,.,.,.,.,0.00117785630153,1/849,.,4.44,179.9,50,0.0,http://exac.broadinstitute.org/gene/ENSG00000196218,0.63290,.,0,D,0.997,D,0.994,D,0.000,U,1.000,D,4.97,17.68,.,.,.,.,.,NM_000540.2(RYR1):c.14761_14762delTTinsAC,DM,Central core disease,16621918,.,.,.,.,"NM_000540.2(RYR1):c.14762T>C(p.F4921S),DM,Central core disease,16621918",.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,activation of JUN kinase activity (GO:0007257)|activation of MAPKKK activity (GO:0000185)|cell proliferation (GO:0008283)|intracellular signal transduction (GO:0035556)|peptidyl-serine phosphorylation (GO:0018105)|protein autophosphorylation (GO:0046777)|protein phosphorylation (GO:0006468)|response to stress (GO:0006950),membrane (GO:0016020),ATP binding (GO:0005524)|MAP kinase kinase kinase kinase activity (GO:0008349)|protein kinase activity (GO:0004672)|protein serine/threonine kinase activity (GO:0004674)|small GTPase regulator activity (GO:0005083),.,.,.,.,4,0,CS000030
399,.,.,OMIM|low_frequency,Name=GCcontent,.,CS000030,264700,"Vitamin D-dependent rickets, type I","1.$$$mimNumber,264700###prefix,####preferredTitle,VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A; VDDR1A###inheritance,Autosomal recessive ###growthOther,Failure to thrive ;###growthOther,Poor growth ;###growthOther,Growth retardation ###headAndNeckHead,Frontal bossing ###headAndNeckTeeth,Delayed tooth eruption ;###headAndNeckTeeth,Enamel hypoplasia ###chestRibsSternumClaviclesAndScapulae,Enlargement of the costochondral junction ;###chestRibsSternumClaviclesAndScapulae,'Bulging' of the costochondral junction ;###chestRibsSternumClaviclesAndScapulae,Deformed rib cage ###abdomenExternalFeatures,Protuberant abdomen due to muscle weakness ###skeletal,Rickets ;###skeletal,Increased fractures ;###skeletal,Bone pain ;###skeletal,Sparse bone trabeculae ;###skeletal,Thin bony cortex ###skeletalSkull,Widened cranial sutures ;###skeletalSkull,Posterior flattening of the skull ###skeletalLimbs,Delayed opacification of the epiphyses ;###skeletalLimbs,Widened, distorted epiphyses ;###skeletalLimbs,'Bulging' epiphyses ;###skeletalLimbs,Frayed, irregular metaphyses ;###skeletalLimbs,Curvatures of the femur, tibia, fibula ;###skeletalLimbs,Lower limb deformities ;###skeletalLimbs,Bowing of the legs ;###skeletalLimbs,Enlargement of the wrists ;###skeletalLimbs,Enlargement of the ankles ;###skeletalLimbs,Subperiosteal erosions due to secondary hyperparathyroidism ###muscleSoftTissue,Hypotonia ;###muscleSoftTissue,Muscle weakness ;###muscleSoftTissue,Difficulty walking ;###muscleSoftTissue,Difficulty standing ###neurologicCentralNervousSystem,Delayed motor development ;###neurologicCentralNervousSystem,Seizures due to hypocalcemia ###neurologicBehavioralPsychiatricManifestations,Irritability ###endocrineFeatures,Secondary hyperparathyroidism ###laboratoryAbnormalities,Hypocalcemia ;###laboratoryAbnormalities,Hypophosphatemia ;###laboratoryAbnormalities,Increased serum parathyroid hormone (PTH) ;###laboratoryAbnormalities,Increased serum alkaline phosphatase ;###laboratoryAbnormalities,Generalized aminoaciduria ;###laboratoryAbnormalities,Markedly decreased or absent serum 1,25-dihydroxyvitamin D3 ;###laboratoryAbnormalities,Normal serum 25-hydroxyvitamin D3 ###miscellaneous,Clinical onset within first 2 years of life ;###miscellaneous,Can be treated with physiologic levels of 1,25-dihydroxyvitamin D3 or 1-alpha-hydroxyvitamin D3 ;###miscellaneous,Increased frequency among French-Canadians from the Charlevoix-Saguenay-Lac Saint Jean area of Quebec (carrier rate 1 in 26) ###molecularBasis,Caused by mutations in the 25-hydroxyvitamin D3-1-alpha-hydroxylase gene (CYP27B1, ).",https://www.omim.org/entry/264700,.,Autosomal recessive,Het,12,58158878,T,C,.,.,PASS,0/1:43:84,51.19,",$.cc,.C,.,CCc.Ccc.Cc,cc,,c.,C.,C,Ccc,,CCc,cc.,cc,,,cc,..,c,,.C,.Ccc.cC,CCc,Cc,.c,c^]C",missense_variant,CYP27B1,1594,.,NM_000785.3(CYP27B1):c.706A>G(p.Met236Val),NM_000785.3,exon4(9),NP=>NP,.,.,0,0,1.628e-05,0.0002,3.23e-05,0.0006,0,1,0.00012,0,1,0.0000084,0.00117785630153,1/849,http://exac.broadinstitute.org/variant/12-58158878-T-C,1.91,16.8,11,0.0,http://exac.broadinstitute.org/gene/ENSG00000111012,0.80135,.,0.51,T,0.025,B,0.055,B,0.000,D,1.000,D,5.06,22.2,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,bone mineralization (GO:0030282)|calcitriol biosynthetic process from calciol (GO:0036378)|calcium ion homeostasis (GO:0055074)|calcium ion transport (GO:0006816)|decidualization (GO:0046697)|G1 to G0 transition (GO:0070314)|negative regulation of calcidiol 1-monooxygenase activity (GO:0010956)|negative regulation of cell growth (GO:0030308)|negative regulation of cell proliferation (GO:0008285)|positive regulation of keratinocyte differentiation (GO:0045618)|positive regulation of vitamin D 24-hydroxylase activity (GO:0010980)|positive regulation of vitamin D receptor signaling pathway (GO:0070564)|regulation of bone mineralization (GO:0030500)|response to estrogen (GO:0043627)|response to interferon-gamma (GO:0034341)|response to lipopolysaccharide (GO:0032496)|response to vitamin D (GO:0033280)|small molecule metabolic process (GO:0044281)|steroid metabolic process (GO:0008202)|vitamin D catabolic process (GO:0042369)|vitamin D metabolic process (GO:0042359)|vitamin metabolic process (GO:0006766)|xenobiotic metabolic process (GO:0006805),cytoplasm (GO:0005737)|mitochondrial outer membrane (GO:0005741)|mitochondrion (GO:0005739),calcidiol 1-monooxygenase activity (GO:0004498)|heme binding (GO:0020037)|iron ion binding (GO:0005506),.,.,.,.,70,2,CS000030
433,.,.,OMIM|novel,Name=GCcontent,.,CS000030,100800;109800;610474;603956;114500;612247;146000;149730;602849;162900;616482;273300;187600;187601,"Achondroplasia;Bladder cancer, somatic;CATSHL syndrome;Cervical cancer, somatic;Colorectal cancer, somatic;Crouzon syndrome with acanthosis nigricans;Hypochondroplasia;LADD syndrome;Muenke syndrome;Nevus, epidermal, somatic;SADDAN;Spermatocytic seminoma, somatic;Thanatophoric dysplasia, type I;Thanatophoric dysplasia, type II","1.$$$mimNumber,100800###prefix,####preferredTitle,ACHONDROPLASIA; ACH###inheritance,Autosomal dominant ###growthHeight,Short-limb dwarfism identifiable at birth ;###growthHeight,Mean male adult height, 131 cm ;###growthHeight,Mean female height, 124 cm ###headAndNeckHead,Frontal bossing ;###headAndNeckHead,Megalencephaly ###headAndNeckFace,Midface hypoplasia ###headAndNeckEars,Recurrent otitis media in infancy and childhood ;###headAndNeckEars,Conductive hearing loss ###headAndNeckNose,Low nasal bridge ###respiratoryAirways,Upper airway obstruction ###skeletal,Generalized joint laxity ###skeletalSkull,Jugular bulb dehiscence (in some patients) ;###skeletalSkull,Foramen magnum stenosis ###skeletalSpine,Lumbar kyphosis in infancy ;###skeletalSpine,Exaggerated lumbar lordosis during childhood and adulthood ;###skeletalSpine,Congenital spinal stenosis due to short pedicles, especially lumbar ;###skeletalSpine,Progressive interpediculate narrowing in lumbar spine ###skeletalPelvis,Dysplastic ilium ;###skeletalPelvis,Narrow sacroiliac groove ;###skeletalPelvis,Flat rooted acetabulae ###skeletalLimbs,Bowing of legs ;###skeletalLimbs,Rhizomelic shortening ;###skeletalLimbs,Short femoral neck ;###skeletalLimbs,Metaphyseal flaring ;###skeletalLimbs,Limited elbow and hip extension ###skeletalHands,Brachydactyly ;###skeletalHands,Trident hand ###neurologicCentralNervousSystem,Hydrocephalus, occasional ;###neurologicCentralNervousSystem,Hypotonia in infancy and early childhood ;###neurologicCentralNervousSystem,Brain stem compression ;###neurologicCentralNervousSystem,Delayed motor development ###miscellaneous,Autosomal dominant with complete penetrance ;###miscellaneous,80% cases new mutations ;###miscellaneous,99+% of the mutations are FGFR3, G380R ();###miscellaneous,Paternal age effect ###molecularBasis,Caused by mutation in the fibroblast growth factor receptor-3 gene (FGFR3, ) 2.$$$mimNumber,610474###prefix,####preferredTitle,CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME; CATSHLS###inheritance,Autosomal dominant (1 family) ;###inheritance,Autosomal recessive (1 family) ###growthHeight,Tall stature (male mean adult height 195.6cm, female mean adult height 177.8cm) ###headAndNeckHead,Microcephaly ###headAndNeckEars,Hearing loss, sensorineural ###headAndNeckMouth,High-arched palate (in some patients) ###chestRibsSternumClaviclesAndScapulae,Pectus excavatum ###skeletalSpine,Scoliosis ;###skeletalSpine,Tall vertebral bodies ###skeletalLimbs,Broad femoral metaphyses ;###skeletalLimbs,Osteochondroma ;###skeletalLimbs,Long limbs ;###skeletalLimbs,Lateral deviation of tibiae (1 family) ###skeletalHands,Camptodactyly ;###skeletalHands,Arachnodactyly ###skeletalFeet,Camptodactyly ###neurologicCentralNervousSystem,Developmental delay ;###neurologicCentralNervousSystem,Mental retardation (in some patients) ###miscellaneous,CATSHL is an acronym for Camptodactyly, Tall Stature, Scoliosis, and Hearing Loss ;###miscellaneous,One family with autosomal dominant inheritance has been reported and 1 family with autosomal recessive inheritance has been reported (last curated October 2014) ###molecularBasis,Caused by mutation in the fibroblast growth factor receptor 3 gene (FGFR3, ) 3.$$$mimNumber,612247###prefix,####preferredTitle,CROUZON SYNDROME WITH ACANTHOSIS NIGRICANS; CAN###inheritance,Autosomal dominant ###headAndNeckHead,Brachycephaly ###headAndNeckFace,Midface hypoplasia ###headAndNeckEyes,Proptosis ;###headAndNeckEyes,Hypertelorism ###headAndNeckNose,Choanal atresia ###genitourinaryInternalGenitaliaFemale,Ovarian cysts (in some patients) ###skeletalSkull,Craniosynostosis ###skinNailsHairSkin,Acanthosis nigricans (neck, axilla, groin, periorbital region, perioral region) ;###skinNailsHairSkin,Verrucous hyperplasia ;###skinNailsHairSkin,Hyperpigmentation ;###skinNailsHairSkin,Hypopigmentation of surgical scars ;###skinNailsHairSkin,Melanocytic nevi ;###skinNailsHairSkin,Skin hypertrophy, particularly in flexural areas ;###skinNailsHairSkin,Generalized skin thickening (particularly over the trunk) ;###skinNailsHairSkin,Warty acanthomas ###skinNailsHairSkinHistology,Papillomatosis with overlying thin, slightly hyperpigmented epidermis ###neurologicCentralNervousSystem,Hydrocephalus (in some patients) ###miscellaneous,Onset of acanthosis nigricans in childhood or by puberty ###molecularBasis,Caused by mutation (A391E) in the fibroblast growth factor receptor 3 gene (FGFR3, ) 4.$$$mimNumber,146000###prefix,####preferredTitle,HYPOCHONDROPLASIA; HCH###inheritance,Autosomal dominant ###growthHeight,Short-limb dwarfism identifiable during childhood ;###growthHeight,Final height, 125 to 160 cm ###headAndNeckHead,Macrocephaly ;###headAndNeckHead,Mild frontal bossing ###headAndNeckFace,Normal/mild midface hypoplasia ###skeletalSpine,Variable lumbar lordosis ;###skeletalSpine,Progressive narrowing of interpediculate distance in the lumbar vertebrate ###skeletalPelvis,Short, squared ilia ###skeletalLimbs,Shortened limbs ;###skeletalLimbs,Short tubular bones with mild metaphyseal flare ;###skeletalLimbs,Limited extension at elbows ;###skeletalLimbs,Genu varum ;###skeletalLimbs,Bowleg ###skeletalHands,Lack of trident hand helps distinguish it from achondroplasia ;###skeletalHands,Brachydactyly ###skinNailsHairSkin,Acanthosis nigricans (rare) ###neurologicCentralNervousSystem,Occasional mental retardation ###miscellaneous,Genetic heterogeneity, some patients not linked to FGFR3 ###molecularBasis,Caused by mutation in the fibroblast growth factor receptor-3 gene (FGFR3, ) 5.$$$mimNumber,149730###prefix,####preferredTitle,LACRIMOAURICULODENTODIGITAL SYNDROME; LADD###inheritance,Autosomal dominant ###headAndNeckFace,Broad forehead ###headAndNeckEars,Simple, cup-shaped ears ;###headAndNeckEars,Hearing loss, mixed conductive-sensorineural ###headAndNeckEyes,Alacrima (dry eye syndrome) ;###headAndNeckEyes,Nasolacrimal duct obstruction ;###headAndNeckEyes,Aplastic/hypoplastic lacrimal puncta ;###headAndNeckEyes,Aplastic/hypoplastic lacrimal glands ;###headAndNeckEyes,Hypertelorism ;###headAndNeckEyes,Telecanthus ;###headAndNeckEyes,Downslanting palpebral fissures ;###headAndNeckEyes,Dacryocystitis ;###headAndNeckEyes,Partially reduced visually acuity ;###headAndNeckEyes,Recurrent corneal ulcerations ;###headAndNeckEyes,Corneal perforation ;###headAndNeckEyes,Limbal stem cell deficiency ;###headAndNeckEyes,Corneal sensitivity impairment (hypesthesia) ###headAndNeckMouth,Absent Stensen duct ;###headAndNeckMouth,Absent parotid gland ;###headAndNeckMouth,Dry mouth ;###headAndNeckMouth,Oral candidiasis ###headAndNeckTeeth,Hypodontia ;###headAndNeckTeeth,Peg-shaped incisors ;###headAndNeckTeeth,Enamel hypoplasia ;###headAndNeckTeeth,Delayed eruption of primary teeth ;###headAndNeckTeeth,Dental caries, severe ###genitourinaryExternalGenitaliaMale,Coronal hypospadias ###genitourinaryKidneys,Renal agenesis ;###genitourinaryKidneys,Nephrosclerosis ###skeletalLimbs,Short radius ;###skeletalLimbs,Short ulna ###skeletalHands,Preaxial polydactyly ;###skeletalHands,Digitalized thumb ;###skeletalHands,Triphalangeal thumb ;###skeletalHands,Thenar muscle hypoplasia ;###skeletalHands,Syndactyly, 2-3 finger ;###skeletalHands,Clinodactyly, 3,5 finger ;###skeletalHands,Bifid thumb ###skeletalFeet,Broad halluces ;###skeletalFeet,Syndactyly, 2-3, 3-4 toe ###molecularBasis,Caused by mutation in the fibroblast growth factor receptor 2 gene (FGFR2, );###molecularBasis,Caused by mutation in the fibroblast growth factor receptor 3 gene (FGFR3, );###molecularBasis,Caused by mutation in the fibroblast growth factor 10 gene (FGF10, ) 6.$$$mimNumber,602849###prefix,####preferredTitle,MUENKE SYNDROME; MNKES###inheritance,Autosomal dominant ###growthHeight,Normal height ###headAndNeckHead,Brachycephaly ;###headAndNeckHead,Macrocephaly ;###headAndNeckHead,Plagiocephaly ###headAndNeckFace,Midface hypoplasia ;###headAndNeckFace,Low-set frontal hairline ###headAndNeckEars,Hearing loss, sensorineural ###headAndNeckEyes,Hypertelorism ;###headAndNeckEyes,Downslanting palpebral fissures ;###headAndNeckEyes,Ptosis ###headAndNeckMouth,High-arched palate ###skeletalSkull,Coronal craniosynostosis (unicoronal or bicoronal, unilateral or bilateral) ;###skeletalSkull,Bulging of temporal fossae ###skeletalHands,Clinodactyly ;###skeletalHands,Brachydactyly ;###skeletalHands,Coned epiphyses ;###skeletalHands,Broad, thimble-like middle phalanges ;###skeletalHands,Capitate-hamate fusions ###skeletalFeet,Broad halluces ;###skeletalFeet,Short middle phalanges ;###skeletalFeet,Calcaneocuboidal fusions ;###skeletalFeet,Coned epiphyses ###skinNailsHairHair,Low-set frontal hairline ###neurologicCentralNervousSystem,Developmental delay ;###neurologicCentralNervousSystem,Mental retardation ###miscellaneous,Females more severely affected than males ;###miscellaneous,Significant phenotypic variability ;###miscellaneous,Birth rate of 7.6 per 1,000,000 ###molecularBasis,Caused by mutation in the fibroblast growth factor receptor 3 gene (FGFR3, ) 7.$$$mimNumber,162900###prefix,####preferredTitle,NEVUS, EPIDERMAL###inheritance,Somatic ###skinNailsHairSkin,Multiple nevi ;###skinNailsHairSkin,Pigmented moles ;###skinNailsHairSkin,Woolly hair nevus (in some patients) ;###skinNailsHairSkin,Hyperpigmented patches of skin (in some patients) ;###skinNailsHairSkin,Raised, scaly, and/or hyperkeratotic areas of skin (in some patients) ###skinNailsHairHair,Patches of tightly curled scalp hair adjacent to straight hair (in some patients) ###molecularBasis,Caused by somatic mutation in the neuroblastoma RAS viral (v-ras) oncogene homolog gene (NRAS, );###molecularBasis,Caused by somatic mutation in the phosphatidylinositol 3-kinase, catalytic, alpha polypeptide gene (PIK3CA, );###molecularBasis,Caused by somatic mutation in the fibroblast growth factor receptor-3 gene (FGFR3, );###molecularBasis,Caused by somatic mutation in the Harvey rat sarcoma viral (v-Ha-ras) oncogene homolog gene (HRAS, ) 8.$$$mimNumber,616482###prefix,####preferredTitle,ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN###inheritance,Autosomal dominant ###growthHeight,Dwarfism ;###growthHeight,Short stature, severe disproportionate ###headAndNeckHead,Megalencephaly ;###headAndNeckHead,Large anterior fontanel ###headAndNeckFace,Midface hypoplasia ;###headAndNeckFace,Frontal bossing ###headAndNeckEars,Hearing loss, mild-to-moderate ;###headAndNeckEars,Otitis media ###headAndNeckEyes,Exotropia (in some patients) ;###headAndNeckEyes,High myopia (in some patients) ###headAndNeckNose,Depressed nasal bridge ###cardiovascularHeart,Congestive heart failure (in some patients) ###cardiovascularVascular,Pulmonary hypertension (in some patients) ###respiratory,Respiratory compromise at birth ;###respiratory,Sleep apnea ###chestExternalFeatures,Small chest with flaring costal margins ###abdomenGastrointestinal,Gastroesophageal reflux (in some patients) ###skeletalSkull,Overgrowth of mandible in adults ;###skeletalSkull,Pneumatization of the sinuses ###skeletalSpine,Platyspondyly ;###skeletalSpine,Kyphosis ;###skeletalSpine,Lumbar lordosis ;###skeletalSpine,Cervical spinal stenosis ###skeletalPelvis,Posterior rotation of hips ###skeletalLimbs,Rhizomelia ;###skeletalLimbs,Mesomelia ;###skeletalLimbs,Anterior bowing of femora ;###skeletalLimbs,Posterior bowing of tibiae ###skinNailsHairSkin,Redundant skin folds on upper and lower limbs ;###skinNailsHairSkin,Acanthosis nigricans ###neurologicCentralNervousSystem,Seizures ;###neurologicCentralNervousSystem,Hydrocephalus ;###neurologicCentralNervousSystem,Central apnea ;###neurologicCentralNervousSystem,Developmental delay ;###neurologicCentralNervousSystem,Limited language acquisition ;###neurologicCentralNervousSystem,Mental retardation, moderate to profound ;###neurologicCentralNervousSystem,Thin corpus callosum ###miscellaneous,Clinical overlap with thanatophoric dysplasia I ()###molecularBasis,Caused by mutation in the fibroblast growth factor receptor-3 gene (FGFR3, ) 9.$$$mimNumber,273300###prefix,####preferredTitle,TESTICULAR GERM CELL TUMOR; TGCT###inheritance,Somatic mutation ###genitourinaryInternalGenitaliaMale,Painless testicular mass ###neoplasia,Male germ cell tumors (GCT), 2 subtypes - ;###neoplasia,Seminoma ;###neoplasia,Nonseminoma (embryonal carcinoma, teratoma, choriocarcinoma, endodermal sinus tumor) ###laboratoryAbnormalities,Isochromosome 12p (i(12p)) ;###laboratoryAbnormalities,Elevated hCG (choriocarcinoma) ;###laboratoryAbnormalities,Elevated AFP (endodermal sinus tumor) ;###laboratoryAbnormalities,Elevated hCG or AFP or both (embryonal carcinoma) ;###laboratoryAbnormalities,Azoospermia/oligospermia (present at diagnosis) ###miscellaneous,Two subtypes - seminoma and nonseminoma ;###miscellaneous,Occasionally germ cell tumor arise from extra gonadal site (e.g., mediastinum, retroperitoneum, pineal gland) ;###miscellaneous,Most common cancer in men aged 15-40 years ;###miscellaneous,Highest incidence in men of European descent ;###miscellaneous,Risk factors for development of TGCT - family history, cryptorchidism (), Klinefelter syndrome, previous TGCT, gonadal dysgenesis 10.$$$mimNumber,187600###prefix,####preferredTitle,THANATOPHORIC DYSPLASIA, TYPE I; TD1###inheritance,Autosomal dominant ###growthHeight,Dwarfism, lethal micromelic ###growthOther,Severe growth deficiency in survivors ###headAndNeckHead,Frontal bossing ;###headAndNeckHead,Macrocephaly ###headAndNeckFace,Small face ###respiratoryLung,Respiratory insufficiency/failure ###chestExternalFeatures,Narrow thorax ###chestRibsSternumClaviclesAndScapulae,Wide-cupped costochondral junctions ;###chestRibsSternumClaviclesAndScapulae,Small abnormally formed scapulae ;###chestRibsSternumClaviclesAndScapulae,Short ribs ###skeletalSkull,Small foramen magnum ;###skeletalSkull,Cloverleaf skull rarely ###skeletalSpine,Severe platyspondyly ###skeletalPelvis,Short and small iliac bones ;###skeletalPelvis,Small sacroiliac notches ###skeletalLimbs,Marked shortness and bowing of long bones ;###skeletalLimbs,'French telephone receiver femurs' ;###skeletalLimbs,Flared and irregular metaphyses ###neurologicCentralNervousSystem,Temporal lobe heterotopias ;###neurologicCentralNervousSystem,Hydrocephalus ;###neurologicCentralNervousSystem,Profound mental retardation and hypotonia in survivors ###prenatalManifestations,Prenatal diagnosis by ultrasound ###prenatalManifestationsMovement,Decreased fetal activity ###prenatalManifestationsAmnioticFluid,Polyhydramnios ###miscellaneous,Death in majority of infants soon after birth ###molecularBasis,Caused by mutation in the fibroblast growth factor receptor-3 gene (FGFR3, ) 11.$$$mimNumber,187601###prefix,####preferredTitle,THANATOPHORIC DYSPLASIA, TYPE II; TD2###inheritance,Autosomal dominant ###growthHeight,Dwarfism, lethal micromelic ###headAndNeckHead,Clover leaf head ###headAndNeckFace,Small face ###respiratoryLung,Respiratory insufficiency ###chestExternalFeatures,Narrow thorax ###chestRibsSternumClaviclesAndScapulae,Wide-cupped costochondral junctions ;###chestRibsSternumClaviclesAndScapulae,Small abnormally formed scapula ;###chestRibsSternumClaviclesAndScapulae,Short ribs ###skeletalSkull,Severe cloverleaf skull (Kleeblattschaedel) ;###skeletalSkull,Small foramen magnum ###skeletalSpine,Platyspondyly ###skeletalPelvis,Short and small iliac bones ;###skeletalPelvis,Small sacroiliac notches ###skeletalLimbs,Straight femurs ;###skeletalLimbs,Flared and irregular metaphyses ###skeletalHands,Brachydactyly ###prenatalManifestations,Prenatal diagnosis by ultrasound ###prenatalManifestationsMovement,Decreased fetal activity ###prenatalManifestationsAmnioticFluid,Polyhydramnios ###miscellaneous,Death in majority of infants soon after birth ###molecularBasis,Caused by mutation in the fibroblast growth factor receptor-3 gene (FGFR3, )",https://www.omim.org/entry/100800;https://www.omim.org/entry/109800;https://www.omim.org/entry/610474;https://www.omim.org/entry/603956;https://www.omim.org/entry/114500;https://www.omim.org/entry/612247;https://www.omim.org/entry/146000;https://www.omim.org/entry/149730;https://www.omim.org/entry/602849;https://www.omim.org/entry/162900;https://www.omim.org/entry/616482;https://www.omim.org/entry/273300;https://www.omim.org/entry/187600;https://www.omim.org/entry/187601,.,"Autosomal dominant;Autosomal recessive, Autosomal dominant",Het,4,1808267,C,T,.,.,PASS,0/1:26:47,55.32,"TTTT....Tt..T.tTT,tT..tTt.T.,TTT.t..TT..,tT",splice_region_variant;splice_region_variant;splice_region_variant,FGFR3,2261,.,NM_000142.4(FGFR3):c.2031-6C>T;NM_001163213.1(FGFR3):c.2037-6C>T;NM_022965.3(FGFR3):c.1695-6C>T,NM_000142.4,intron15(17);intron15(17);intron13(15),.;.;.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,0.00117785630153,1/849,.,1.39,25.4,9,0.0,http://exac.broadinstitute.org/gene/ENSG00000068078,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,alveolar secondary septum development (GO:0061144)|axonogenesis involved in innervation (GO:0060385)|bone maturation (GO:0070977)|bone mineralization (GO:0030282)|bone morphogenesis (GO:0060349)|cell-cell signaling (GO:0007267)|central nervous system myelination (GO:0022010)|chondrocyte differentiation (GO:0002062)|chondrocyte proliferation (GO:0035988)|cochlea development (GO:0090102)|digestive tract morphogenesis (GO:0048546)|endochondral bone growth (GO:0003416)|endochondral ossification (GO:0001958)|epidermal growth factor receptor signaling pathway (GO:0007173)|epithelial cell fate commitment (GO:0072148)|Fc-epsilon receptor signaling pathway (GO:0038095)|fibroblast growth factor receptor apoptotic signaling pathway (GO:1902178)|fibroblast growth factor receptor signaling pathway (GO:0008543)|innate immune response (GO:0045087)|inner ear receptor cell differentiation (GO:0060113)|insulin receptor signaling pathway (GO:0008286)|JAK-STAT cascade (GO:0007259)|lens fiber cell development (GO:0070307)|lens morphogenesis in camera-type eye (GO:0002089)|MAPK cascade (GO:0000165)|morphogenesis of an epithelium (GO:0002009)|negative regulation of astrocyte differentiation (GO:0048712)|negative regulation of developmental growth (GO:0048640)|negative regulation of epithelial cell proliferation (GO:0050680)|negative regulation of mitosis (GO:0045839)|negative regulation of smoothened signaling pathway (GO:0045879)|negative regulation of transcription from RNA polymerase II promoter (GO:0000122)|neurotrophin TRK receptor signaling pathway (GO:0048011)|peptidyl-tyrosine phosphorylation (GO:0018108)|phosphatidylinositol-mediated signaling (GO:0048015)|positive regulation of canonical Wnt signaling pathway (GO:0090263)|positive regulation of cell differentiation (GO:0045597)|positive regulation of cell proliferation (GO:0008284)|positive regulation of endothelial cell proliferation (GO:0001938)|positive regulation of ERK1 and ERK2 cascade (GO:0070374)|positive regulation of MAPK cascade (GO:0043410)|positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway (GO:0090080)|positive regulation of neuron apoptotic process (GO:0043525)|positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552)|positive regulation of phospholipase activity (GO:0010518)|positive regulation of protein ubiquitination (GO:0031398)|positive regulation of tyrosine phosphorylation of Stat1 protein (GO:0042511)|positive regulation of tyrosine phosphorylation of Stat3 protein (GO:0042517)|protein autophosphorylation (GO:0046777)|response to axon injury (GO:0048678)|skeletal system development (GO:0001501)|somatic stem cell maintenance (GO:0035019)|substantia nigra development (GO:0021762),cell surface (GO:0009986)|cytoplasmic side of plasma membrane (GO:0009898)|cytoplasmic vesicle (GO:0031410)|endoplasmic reticulum (GO:0005783)|extracellular region (GO:0005576)|integral component of plasma membrane (GO:0005887)|lysosome (GO:0005764)|nucleus (GO:0005634)|perinuclear region of cytoplasm (GO:0048471)|plasma membrane (GO:0005886),ATP binding (GO:0005524)|fibroblast growth factor binding (GO:0017134)|fibroblast growth factor-activated receptor activity (GO:0005007)|protein tyrosine kinase activity (GO:0004713),.,.,.,.,91,4,CS000030
